| Patient | Joe Louis |
|---|---|
| Date of birth | 1914-05-13 |
| Identifiers | MRN HR-BX002-SYN-TD; SSN (made up) 000-02-6639 |
| Document date | 1969-09-21 |
| Author | Desmond Achterberg-Cole, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Ten-week review: remission, antipsychotic taper, cognition and the echocardiogram. [S]
Mr. Louis returns one week after his preventive visit. He has had no persecutory beliefs for about six weeks and sleeps six to seven hours. In the last week of August he was out of town for four days of paid appearances and missed two urine tests; the day after he came home, with an old acquaintance, he used cocaine on one day. He reported it himself at his next test, which was positive, and all tests since have been negative. He had no psychotic symptoms after that use. His stool test kit came back negative. His home readings average 128/80 mmHg. The echocardiogram was done this morning. [S]
| Element | Detail |
|---|---|
| Cocaine | One day of use three weeks ago, reported by him; none since |
| Urine tests | Two missed while away; one positive after the lapse; the rest negative |
| Psychotic symptoms | None for six weeks, including after the lapse |
| Home blood pressure | Average 128/80 mmHg |
| Stool test | Negative |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy good |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Neurological | Negative | No memory lapses, restlessness or tremor |
| Psychiatric | Negative | No persecutory beliefs; disappointed by the lapse but steady; no thoughts of suicide or of harming anyone |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Naloxone 4 mg nasal spray, one spray into one nostril for a suspected opioid overdose, repeated every two to three minutes in the other nostril if needed; two-pack dispensed, with fentanyl test strips and instruction for him and anyone he lives with | One spray as needed for suspected overdose; repeat in 2 to 3 minutes if needed | Nasal route | 1969-07-13 | active | S |
| Aripiprazole 5 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 1969-07-20 to 1969-09-21 | completed | S |
| Aripiprazole 2 mg oral tablet, one tablet each morning for two weeks, then stop | One tablet each morning for two weeks, then stop | Oral route | 1969-09-21 to 1969-10-05 | completed | S |
| Amlodipine 5 mg oral tablet, one tablet daily | One tablet daily | Oral route | 1969-08-10 | active | S |
| Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestion | Two sprays in each nostril up to every 4 hours as needed | Nasal route | 1969-08-03 to 1969-08-08 | completed | S |
| Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for sore throat or aches, no more than 3,000 mg a day | One or two tablets every 6 hours as needed, no more than 3,000 mg a day | Oral route | 1969-08-03 to 1969-08-08 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1969-09-21 | Body height | 187 | cm | S |
| 1969-09-21 | Body weight | 102.1 | kg | S |
| 1969-09-21 | Body mass index (BMI) [Ratio] | 29.2 | kg/m2 | S |
| 1969-09-21 | Systolic blood pressure | 130 | mm[Hg] | S |
| 1969-09-21 | Diastolic blood pressure | 82 | mm[Hg] | S |
| 1969-09-21 | Heart rate | 74 | /min | S |
| 1969-09-21 | Respiratory rate | 16 | /min | S |
| 1969-09-21 | Body temperature | 36.6 | Cel | S |
| 1969-09-21 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1969-09-21 | Left ventricular Ejection fraction | 60 | % | 52-72% | Normal | S |
| 1969-09-21 | Total score [MoCA] | 27 | {score} | S | ||
| 1969-09-21 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S |
Vital signs recorded on 1969-09-21; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 130/82, pulse 74; weight 102.1 kg, BMI 29.2 |
| Cardiovascular | Regular rhythm; no murmur; no ankle edema |
| Neurological | No tremor, rigidity or abnormal movements; no akathisia |
| Psychiatric | Calm and engaged; no delusional content; MoCA 27 |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Persecutory thoughts and poor sleep for about two months: a fixed belief that people are following him and plan to harm him, three to four hours of sleep a night, partial insight; cause under evaluation | resolved | confirmed | R41.89 | S — Synthetic presenting problem anchored to his documented fears of a plot against his life; resolved into the diagnosis at the consultation. Not a claim about his real symptoms. |
| Cocaine use disorder, severe (seven of eleven DSM-5-TR criteria): intranasal cocaine most days for about a year, last use three days before intake | resolved | confirmed | F14.20 | S — Synthetic modern coding at intake; superseded at the consultation by the combined code once the psychotic disorder was diagnosed. Person-first language; not a claim about his real diagnosis. |
| Cocaine use disorder, severe, with cocaine-induced psychotic disorder (persecutory delusions during heavy use, persisting ten days after the last use, with no history of psychosis off cocaine, a normal examination and no evidence of a neurocognitive disorder); psychotic symptoms resolved within four weeks on aripiprazole | active | confirmed | F14.250 | S — Synthetic modern diagnosis made at the consultation. Not a claim about his real diagnosis. |
| Raised blood pressure at intake (154/98 mmHg) three days after cocaine use, without a diagnosis of hypertension; home readings planned | resolved | confirmed | R03.0 | S — Synthetic presenting finding; resolved into a diagnosis of hypertension at four weeks. |
| Hypertension, stage 2, confirmed four weeks after the last cocaine use (clinic 146/92, home average 144/90 mmHg), with mild concentric left ventricular hypertrophy and a normal aortic root on echocardiography; treated with amlodipine | active | confirmed | I10 | S — Synthetic modern diagnosis made at the four-week visit. |
| Financial insecurity: years of tax debt from his time as a well-paid athlete, now settled, left him with no savings; irregular income from paid appearances; worry about money keeps him awake | active | confirmed | Z59.86 | S — Synthetic social need anchored to his documented tax debt. |
| Acute viral upper respiratory infection (common cold) for three days; rapid tests negative for influenza and COVID-19; resolved within ten days without antibiotics | resolved | confirmed | J06.9 | S — Synthetic acute illness; not a historical claim. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Self-management | Cocaine use since the last visit (his own account), cravings and triggers | Every visit | Completed today | One day of use about three weeks ago; none since |
| Laboratory | Urine drug tests in contingency management, with fentanyl, and prize draws for negative results | Twice weekly for twelve weeks, then at visits | Deferred | Two tests were missed while he was away for four days in late August, and he used cocaine on one day after returning; the next test was positive and all later tests negative. No lasting harm: he reported the use himself, had no psychotic symptoms and stopped at once. Corrective action: a travel plan with testing at a partner clinic and phone therapy sessions |
| Examination | Psychotic symptoms, insight and sleep | Every visit | Completed today | No psychotic symptoms for six weeks, including after the lapse |
| Medication safety | Antipsychotic safety: weight, blood pressure, akathisia (Barnes scale) and abnormal movements (AIMS) | Weight and akathisia at every visit while on treatment; AIMS at baseline and every six months | Completed today | Weight 102.1 kg, up 1.1 kg since starting; no akathisia or abnormal movements; taper to 2 mg today |
| Laboratory | Fasting glucose or hemoglobin A1c and lipids on an antipsychotic | Baseline, at four months, then yearly | Up to date | Baseline done; the four-month check will not be needed if aripiprazole stops as planned |
| Examination | Cognitive screen (MoCA) | At baseline and again once he is well and off cocaine | Completed today | MoCA 27, normal, after ten weeks well |
| Examination | Blood pressure in clinic and at home | Every visit; home readings before diagnosis and after each change | Completed today | Clinic 130/82; home average 128/80 mmHg on amlodipine |
| Imaging | Echocardiogram for stage 2 hypertension or left ventricular hypertrophy | At diagnosis | Completed today | Ejection fraction 60%; mild concentric left ventricular hypertrophy; aortic root 3.6 cm and ascending aorta 3.5 cm |
| Survey | Suicide and violence risk review, safety plan and the 988 Suicide & Crisis Lifeline | Every visit | Completed today | No thoughts of suicide or of harming anyone after the lapse |
| Medication safety | Naloxone and fentanyl test strips on hand | Every visit | Completed today | Naloxone at home; he used a test strip the day of the lapse |
| Survey | Depression (PHQ-9) and anxiety (GAD-7) | At baseline and every four weeks while in treatment | Completed today | PHQ-9 3, item 9 scored 0; PHQ-2 0 at the preventive visit |
| Self-management | Cognitive behavioral therapy | Weekly | Completed today | Eight of nine sessions attended; the missed one was during the trip |
| Self-management | Finances, social work and taxpayer services | Every visit | Completed today | Tax clinic appointment kept; awaiting their review |
| Self-management | Family involvement, only with his consent | Every visit | Completed today | No family contact requested by him |
Goal progress:
Guideline basis: The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder (2023); The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia (2020); Treatment for Stimulant Use Disorders (Treatment Improvement Protocol 33, updated 2021) (2021); National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021); 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and depression, bipolar, and mood disorders monographs (2026)
Follow-up: Fifteen-week review in five weeks, after the taper. Contingency management to the end of twelve weeks; therapy weekly. Call the clinic or 988 if the fears or sleeplessness return. Next scheduled visit 1969-10-26: fifteen-week review off the antipsychotic: recovery, blood pressure and finances. [S]